Current Issue

March 22, 2018: 131 (12)
Blood: 131 (12)

First Edition


  • Review Series: Strategies to Improve GVL Effects

    Robert Zeiser, MD, and Michel Sadelain, MD, PhD discuss highlights of this review series which explores exciting new developments in treatments to enhance graft-versus-leukemia (GVL) effects in hematopoietic cell transplantation, including cellular therapies, antibody-based treatments, and drug-based approaches using tyrosine kinase inhibitors and checkpoint blockade

  • Review Series: Hematologic Disease at Older Age

    Gerald de Haan, PhD and Gregory A. Abel, MD, MPH discuss highlights of this review series which highlights common biologic and clinical concepts related to hematologic disease associated with aging.

  • Review Series: Therapeutic Antibodies

    Ken H. Young, MD, PhD shares some highlights of this review series which describes the emerging mechanistic insights and therapeutic value of different classes of antibody therapy, including direct antibodies; “accelerator” antibodies against coreceptors; and antibodies reversing regulatory T-cell activity, for a variety of hematological malignancies.